# Specific PET Radioligand Binding to Translocator Protein

> **NCT02181582** · PHASE1 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 32 (actual)

## Conditions studied

- Baseline
- Blocking Receptor Binding

## Interventions

- **DRUG:** Emapunil
- **DEVICE:** PET

## Key facts

- **NCT ID:** NCT02181582
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-24
- **Primary completion:** 2016-06-16
- **Final completion:** 2016-11-23
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02181582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02181582, "Specific PET Radioligand Binding to Translocator Protein". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02181582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*